TuHURA Biosciences, Inc./NV (HURA) reporting calendar
TuHURA Biosciences, Inc./NV files periodic reports with the SEC as HURA on Nasdaq. Atlas tracks 61 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 18 Jul 2026 – 10 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 15 May 2026
- Reports on record
- 61
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open HURA market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 15 May 2026 | 45 days | 0001193125-26-227245 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001193125-26-134950 |
| 10-Q | 30 Sep 2025 | 14 Nov 2025 | 45 days | 0001193125-25-281539 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0000950170-25-108972 |
| 10-Q | 31 Mar 2025 | 15 May 2025 | 45 days | 0000950170-25-072745 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0000950170-25-047921 |
| 10-Q | 30 Sep 2024 | 14 Nov 2024 | 45 days | 0000950170-24-127199 |
| 10-K | 30 Jun 2024 | 7 Oct 2024 | 99 days | 0000950170-24-113321 |
| 10-Q | 31 Mar 2024 | 14 May 2024 | 44 days | 0000950170-24-059694 |
| 10-Q | 31 Dec 2023 | 14 Feb 2024 | 45 days | 0000950170-24-015204 |
| 10-Q | 30 Sep 2023 | 13 Nov 2023 | 44 days | 0000950170-23-062915 |
| 10-K | 30 Jun 2023 | 18 Sep 2023 | 80 days | 0000950170-23-048588 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0000950170-23-020854 |
| 10-Q | 31 Dec 2022 | 14 Feb 2023 | 45 days | 0000950170-23-002805 |
| 10-Q | 30 Sep 2022 | 9 Nov 2022 | 40 days | 0000950170-22-023988 |
| 10-K | 30 Jun 2022 | 27 Sep 2022 | 89 days | 0000950170-22-018865 |
| 10-Q | 31 Mar 2022 | 13 May 2022 | 43 days | 0000950170-22-009809 |
| 10-Q | 31 Dec 2021 | 11 Feb 2022 | 42 days | 0001564590-22-004688 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0001564590-21-056793 |
| 10-K | 30 Jun 2021 | 28 Sep 2021 | 90 days | 0001564590-21-049235 |
| 10-Q | 31 Mar 2021 | 13 May 2021 | 43 days | 0001564590-21-027558 |
| 10-Q | 31 Dec 2020 | 12 Feb 2021 | 43 days | 0001564590-21-005642 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001564590-20-053563 |
| 10-K | 30 Jun 2020 | 18 Sep 2020 | 80 days | 0001564590-20-044019 |
| 10-Q | 31 Mar 2020 | 13 May 2020 | 43 days | 0001213900-20-011910 |
| 10-Q | 31 Dec 2019 | 13 Feb 2020 | 44 days | 0001213900-20-003470 |
| 10-Q | 30 Sep 2019 | 13 Nov 2019 | 44 days | 0001213900-19-023215 |
| 10-K | 30 Jun 2019 | 9 Sep 2019 | 71 days | 0001213900-19-017497 |
| 10-Q | 31 Mar 2019 | 14 May 2019 | 44 days | 0001213900-19-008562 |
| 10-Q | 31 Dec 2018 | 11 Feb 2019 | 42 days | 0001213900-19-002099 |
| 10-Q | 30 Sep 2018 | 13 Nov 2018 | 44 days | 0001213900-18-015493 |
| 10-K | 30 Jun 2018 | 24 Sep 2018 | 86 days | 0001213900-18-012876 |
| 10-Q | 31 Mar 2018 | 15 May 2018 | 45 days | 0001213900-18-006318 |
| 10-Q | 31 Dec 2017 | 14 Feb 2018 | 45 days | 0001213900-18-001883 |
| 10-Q | 30 Sep 2017 | 9 Nov 2017 | 40 days | 0001213900-17-011667 |
| 10-K | 30 Jun 2017 | 27 Sep 2017 | 89 days | 0001213900-17-010055 |
| 10-Q | 31 Mar 2017 | 12 May 2017 | 42 days | 0001213900-17-005082 |
| 10-Q | 31 Dec 2016 | 10 Feb 2017 | 41 days | 0001213900-17-001208 |
| 10-Q | 30 Sep 2016 | 10 Nov 2016 | 41 days | 0001213900-16-018242 |
| 10-K | 30 Jun 2016 | 13 Sep 2016 | 75 days | 0001213900-16-016715 |
Source: SEC EDGAR company submissions for CIK 0001498382. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.